Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease: miRNA and mRNA Regulation

References

• Global strategy for prevention, diagnosis and management of COPD: 2022 Report. Available from: https://goldcopd.org/2022-gold-reports-2/. Accessed March 28, 2022.
   Google Scholar
• Postma DS, Bush A, van den Berge M. Risk factors and early origins of chronic obstructive pulmonary disease. Lancet. 2015;385(9971):899–909. doi:10.1016/S0140-6736(14)60446-3
   PubMed Web of Science ®Google Scholar
• Berndt A, Leme AS, Shapiro SD. Emerging genetics of COPD. EMBO Mol Med. 2012;4:1144–1155. doi:10.1002/emmm.201100627
   PubMed Web of Science ®Google Scholar
• Sundar IK, Rahman I. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer. Am J Physiol Lung Cell Mol Physiol. 2016;311(6):L1245–L1258. doi:10.1152/ajplung.00253
   PubMed Web of Science ®Google Scholar
• Aguiar JA, Tamminga A, Lobb B, et al. The impact of cigarette smoke exposure, COPD, or asthma status on ABC transporter gene expression in human airway epithelial cells. Sci Rep. 2019;9(1):153. doi:10.1038/s41598-018-36248-9
   PubMed Web of Science ®Google Scholar
• de Vries M, Faiz A, Woldhuis RR, et al. Lung tissue gene-expression signature for the ageing lung in COPD. Thorax. 2017. doi:10.1136/thoraxjnl-2017-210074
   PubMed Web of Science ®Google Scholar
• Morrow JD, Zhou X, Lao T, et al. Functional interactors of three genome-wide association study genes are differentially expressed in severe chronic obstructive pulmonary disease lung tissue. Sci Rep. 2017;7:44232. doi:10.1038/srep44232
   PubMed Web of Science ®Google Scholar
• Morrow JD, Cho MH, Platig J, et al. Ensemble genomic analysis in human lung tissue identifies novel genes for chronic obstructive pulmonary disease. Hum Genomics. 2018;12(1):1. doi:10.1186/s40246-018-0132-z
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Srisuma S, Demeo DL, et al. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol. 2009;40:359–367. doi:10.1165/rcmb.2008-0114OC
   PubMed Web of Science ®Google Scholar
• Savarimuthu Francis SM, Larsen JE, Pavey SJ, et al. Genes and gene ontologies common to airflow obstruction and emphysema in the lungs of patients with COPD. PLoS One. 2011;6(3):e17442. doi:10.1371/journal.pone.0017442
   PubMed Web of Science ®Google Scholar
• Zhong S, Chen C, Liu N, et al. Overexpression of hsa-miR-664a-3p is associated with cigarette smoke-induced chronic obstructive pulmonary disease via targeting FHL1. Int J Chron Obstruct Pulmon Dis. 2019;14:2319–2329. doi:10.2147/COPD.S224763
   PubMed Web of Science ®Google Scholar
• Tang K, Zhao J, Xie J, et al. Decreased miR-29b expression is associated with airway inflammation in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2019;316(4):621–629. doi:10.1152/ajplung.00436.2018
   Web of Science ®Google Scholar
• Xue H, Li MX. MicroRNA-150 protects against cigarette smoke- induced lung inflammation and airway epithelial cell apoptosis through repressing p53: microRNA-150 in CS-induced lung inflammation. Hum Exp Toxicol. 2018;37(9):920–928. doi:10.1177/0960327117741749
   PubMed Web of Science ®Google Scholar
• Shen W, Liu J, Zhao G, et al. Repression of toll-like receptor-4 by microRNA-149-3p is associated with smoking-related COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:705–715. doi:10.2147/COPD.S128031
   PubMed Web of Science ®Google Scholar
• Conickx G, Mestdagh P, Avila Cobos F, et al. MicroRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(1):43–56. doi:10.1164/rccm.201506-1182OC
   PubMed Web of Science ®Google Scholar
• Xu H, Sun Q, Lu L, et al. MicroRNA-218 acts by repressing TNFR1-mediated activation of NF-κB, which is involved in MUC5AC hyper-production and inflammation in smoking-induced bronchiolitis of COPD. Toxicol Lett. 2017;280:171–180. doi:10.1016/j.toxlet.2017.08.079
   PubMed Web of Science ®Google Scholar
• Qu X, Dang X, Wang W, et al. Long noncoding RNAs and mRNA regulation in peripheral blood mononuclear cells of patients with chronic obstructive pulmonary disease. Mediators Inflamm. 2018;2018:7501851. doi:10.1155/2018/7501851
   PubMed Web of Science ®Google Scholar
• Pniewska E, Sokolowska M, Kuprys-Lipinska I, et al. Exacerbating factors induce different gene expression profiles in peripheral blood mononuclear cells from asthmatics, patients with chronic obstructive pulmonary disease and healthy subjects. Int Arch Allergy Immunol. 2014;165(4):229–243. doi:10.1159/000370067
   PubMed Web of Science ®Google Scholar
• Bahr TM, Hughes GJ, Armstrong M, et al. Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2013;49(49):316–323. doi:10.1165/rcmb.2012-0230OC
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065–1072. doi:10.1164/rccm.201110-1792OC
   PubMed Web of Science ®Google Scholar
• Pinto-Plata V, Toso J, Lee K, et al. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax. 2007;62(7):595–601. doi:10.1136/thx.2006.064428
   PubMed Web of Science ®Google Scholar
• Agusti A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483. doi:10.1371/journal.pone.0037483
   PubMed Web of Science ®Google Scholar
• Knobloch J, Chikosi SJ, Yanik S, et al. A systemic defect in toll-like receptor 4 signaling increases lipopolysaccharide-induced suppression of IL-2-dependent T-cell proliferation in COPD. Am J Physiol Lung Cell Mol Physiol. 2016;310(1):L24–L39. doi:10.1152/ajplung.00367.2014
   PubMed Web of Science ®Google Scholar
• Bengoechea JA, Ito K. Chronic obstructive pulmonary disease Th1 cells display impaired response to endotoxin. Am J Respir Crit Care Med. 2011;183(2):148–150. doi:10.1164/rccm.201008-1275ED
   PubMed Web of Science ®Google Scholar
• Knobloch J, Schild K, Jungck D, et al. The T-helper cell type 1 immune response to gram- negative bacterial infections is impaired in COPD. Am J Respir Crit Care Med. 2011;183(2):204–214. doi:10.1164/rccm.201002-0199OC
   PubMed Web of Science ®Google Scholar
• Tan DBA, Teo TH, Setiawan AM, et al. Increased CTLA-4+ T cells may contribute to impaired T helper type 1 immune responses in patients with chronic obstructive pulmonary disease. Immunology. 2017;151(2):219–226. doi:10.1111/imm.12725
   PubMed Web of Science ®Google Scholar
• Rohde G, Radsak MP, Borg I, et al. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease. Respiration. 2012;83(2):133–139. doi:10.1159/000328413
   PubMed Web of Science ®Google Scholar
• Tammaro A, Derive M, Gibot S, et al. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 2017;177:81–95. doi:10.1016/j.pharmthera.2017.02.043
   PubMed Web of Science ®Google Scholar
• Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164(10):4991–4995. doi:10.4049/jimmunol.164.10.4991
   PubMed Web of Science ®Google Scholar
• Radsak MP, Taube C, Haselmayer P, et al. Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol. 2007;2007:52040. doi:10.1155/2007/52040
   PubMedGoogle Scholar
• Wang R, Xu J, Liu H, et al. Peripheral leukocytes as novel biomarkers for COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1101–1112. doi:10.2147/COPD.S130416;.
   PubMed Web of Science ®Google Scholar
• Molina-Pinelo S, Pastor MD, Suarez R, et al. MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD. Eur Respir J. 2014;43(6):1740–1749. doi:10.1183/09031936.00091513
   PubMed Web of Science ®Google Scholar
• Soeda S, Ohyashiki JH, Ohtsuki K, et al. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease. Int J Mol Med. 2013;31(3):533–539. doi:10.3892/ijmm.2013.1251
   PubMed Web of Science ®Google Scholar
• Hua L, Zheng W, Xia H, et al. Integration of multi-microarray datasets to identify chronic obstructive pulmonary disease-related miRNAs. Biomed Mater Eng. 2015;26(Suppl 1):S1903–S1915. doi:10.3233/BME-151493
   PubMed Web of Science ®Google Scholar
• Ezzie ME, Crawford M, Cho JH, et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax. 2012;67(2):122–131. doi:10.1136/thoraxjnl-2011-200089
   PubMed Web of Science ®Google Scholar